Creating an Affordable Pricing Strategy and Market Access Strategy to Introduce a New Epileptic Drug to India
The client, a leading pharma player wanted to launch a new epileptic drug in India and in other developing markets such as Egypt. The focus was on creating an affordable pricing strategy and a market access strategy for India and Egypt.
To develop a pricing model, UC adopted the following approach:
● Developed an overview of the regulatory environment
● Evaluated the pricing strategies of pharmaceutical companies in India and Egypt
● Triangulated primary and secondary research to obtain the market size of anti-epileptic drugs in India
● Collected stakeholder feedback for pricing strategy
The client received a detailed epilepsy market overview in India and Egypt, along with a pricing strategy to be adopted in both countries.